SCHEMBL28572972

SCHEMBL28572972

COC(=O)COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC1CCN(C(=O)N2CCOCC2)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 17/20 0.66
▸ ERBB2 P04626 4/20 0.63
▸ KDR P35968 2/20 0.60
▸ EPHB4 P54760 2/20 0.60
▸ EPHA2 P29317 1/20 0.60
▸ BRAF P15056 2/20 0.58
▸ CIT O14578 1/20 0.58
▸ GAK O14976 1/20 0.58
▸ EPHB6 O15197 1/20 0.58
▸ ABCC4 O15439 1/20 0.58
▸ DAPK3 O43293 1/20 0.58
▸ RIPK2 O43353 1/20 0.58
▸ NR1I2 O75469 1/20 0.58
▸ RPS6KA4 O75676 1/20 0.58
▸ STK17B O94768 1/20 0.58
▸ STK10 O94804 1/20 0.58
▸ PRKD3 O94806 1/20 0.58
▸ ABCB11 O95342 1/20 0.58
▸ MAP4K4 O95819 1/20 0.58
▸ CHEK2 O96017 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1446177 0.92 EGFR (0.68) EGFRERBB2KDREPHB4BRAF
SCHEMBL185479 0.92 EGFR (0.74) EGFRERBB2KDREPHB4EPHA2
SCHEMBL29623589 0.92 EGFR (0.74) EGFRERBB2KDREPHB4EPHA2
SCHEMBL29623541 0.92 EGFR (0.66) EGFRERBB2KDREPHB4BRAF
SCHEMBL175261 0.92 EGFR (0.66) EGFRERBB2KDREPHB4BRAF
SCHEMBL2762294 0.90 EGFR (0.67) EGFRERBB2KDREPHB4EPHA2
SCHEMBL1446518 0.89 EGFR (0.70) EGFRERBB2KDREPHB4EPHA2
SCHEMBL10285951 0.89 EGFR (0.71) EGFRERBB2KDREPHB4EPHA2
SCHEMBL28572975 0.86 EGFR (0.64) EGFRERBB2
SCHEMBL1447161 0.85 EGFR (0.78) EGFRERBB2KDREPHB4EPHA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108026080-B Pyrazolyl-substituted heteroaryl compounds and their use as medicaments 勃林格殷格翰国际有限公司 2021-06-11 — — CN disclosed
Send feedback